Highly Potent Peptide Manufacture
Serious About Difficult Science. Designed for Potent Molecules.
Highly potent compounds present some of the most demanding challenges in pharmaceutical drug development.
From limited toxicological data and evolving containment requirements through to complex handling, scale-up and manufacturing considerations, successful High Potent API (HPAPI) development requires expertise that extends far beyond chemistry alone.
Our multidisciplinary teams combine containment expertise, process chemistry, toxicology assessment, analytical sciences and GMP manufacturing to safely advance highly potent molecules from development through clinical supply.
Managing Risk from the Earliest Stages
Early-phase HPAPI programmes often begin with incomplete data and evolving compound knowledge.
Our approach starts by developing a comprehensive understanding of both the API and key intermediates. Scientists work closely with health and safety specialists, toxicologists, analytical experts and manufacturing teams to establish appropriate containment strategies and operational controls.
This science-led assessment enables informed decisions to be made early, helping programmes progress safely, efficiently and with confidence.
The Expertise to Handle Complex Potency Challenges
Highly potent programmes demand specialist knowledge at every stage of development.
Our teams support:
- Potent and highly potent small molecules
- Early-phase process development
- Clinical API manufacture
- Occupational exposure assessment
- Process scale-up and technology transfer
- Analytical method development and impurity control
- Manufacturing risk assessment
- Containment strategy design
By integrating these disciplines, we help clients navigate both the scientific and operational complexities associated with high-potency compounds.
Containment Designed Around Confidence
When working with highly potent molecules, containment is critical.
Almac Sciences has invested in specialist containment and isolation technologies that enable the safe handling and manufacture of highly potent compounds. Our facilities incorporate dedicated containment systems, isolator technology and operational controls designed to protect personnel, product quality and process integrity throughout development and manufacture.
Our expertise supports compounds with occupational exposure limits down to highly demanding containment thresholds, providing the flexibility required for challenging development programmes.
Science-Led Decision Making
Difficult science requires robust process understanding.
Our teams build detailed knowledge of compound behaviour, process risks and manufacturing requirements to establish effective operating procedures, containment controls and development strategies. This integrated approach helps minimise risk, support regulatory expectations and create a stronger pathway towards successful clinical manufacture.
Integrated Development from Molecule to Manufacture
Highly potent development rarely exists in isolation.
As part of Almac Sciences' broader integrated development offering, HPAPI programmes can be supported by:
- Chemical development and scale-up
- Advanced analytical and solid-state services
- Regulatory and CMC expertise
- Biocatalysis and enabling technologies
- Registered starting material manufacture
- Clinical and commercial API manufacturing
With one team working across the entire programme, clients benefit from scientific continuity, reduced risk and a more efficient route through development.
When Potency Increases, So Does the Need for Expertise
Successfully developing highly potent compounds requires a partner that understands both the science and the practical realities of containment, manufacture and supply.
Serious About Difficult Science. Trusted with Highly Potent Molecules.